Yanfan Chen
- Cancer Research top 2%
- MicroRNA in disease regulation 3
- Molecular Biology top 10%
- Medicinal Plants and Bioactive Compounds 3
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Pulmonary Hypertension Research and Treatments 3
-
- Peptidase Inhibition and Analysis 2
-
- Venous Thromboembolism Diagnosis and Management 2
Yanfan Chen
31 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Cancer Research 654
- Molecular Biology 811
- Infectious Diseases 144
- Pulmonary and Respiratory Medicine 206
- Immunology 131
Countries citing papers authored by Yanfan Chen
This map shows the geographic impact of Yanfan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfan Chen more than expected).
Fields of papers citing papers by Yanfan Chen
This network shows the impact of papers produced by Yanfan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfan Chen. The network helps show where Yanfan Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yanfan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 9 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 2 | |
| 7 | 2021 | 18 | |
| 8 | 2020 | 101 | |
| 9 | 2020 | 32 | |
| 10 | 2018 | 5 | |
| 11 | 2018 | 5 | |
| 12 | Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non–Small Cell Lung Cancer Using Next-Generation Sequencingbreakdown → | 2017 | 437 |
| 13 | 2017 | 282 | |
| 14 | 2016 | 10 | |
| 15 | 2016 | 66 | |
| 16 | Pollution Assessment of As and Hg in Urban Dusts in Kaifeng City Based on Their Background Values | 2015 | 1 |
| 17 | 2015 | 81 | |
| 18 | 2012 | 33 | |
| 19 | 2012 | 13 | |
| 20 | [An experimental study on the regulation of pulmonary arterial remodeling by protein kinase C in chronic hypoxic rats]. | 2002 | 1 |
About Yanfan Chen
Yanfan Chen is a scholar working on Internal Medicine, Process Chemistry and Technology and Cancer Research, having authored 31 papers that have together received 1.4k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), COVID-19 Clinical Research Studies (3 papers), MicroRNA in disease regulation (3 papers), Pulmonary Hypertension Research and Treatments (3 papers), Medicinal Plants and Bioactive Compounds (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Peptidase Inhibition and Analysis (2 papers) and Venous Thromboembolism Diagnosis and Management (2 papers). The work is most often cited by research in Cancer Research (654 citations), Molecular Biology (811 citations) and Infectious Diseases (144 citations). Yanfan Chen has collaborated with scholars based in China, Iran and Taiwan. Frequent co-authors include Keqin Li, Senrui Chen, Liangxing Wang, Hanbin Chen, Shaoran Fei, Baochai Lin, Xiaona Cai, Congying Xie, Huanle Pan and Lanxiao Shen. Their work appears in journals such as Computers in Biology and Medicine, International Immunopharmacology, Frontiers in Neuroinformatics, Clinical Cancer Research and IET Nanobiotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.